0001209191-18-027898.txt : 20180503 0001209191-18-027898.hdr.sgml : 20180503 20180503194216 ACCESSION NUMBER: 0001209191-18-027898 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180501 FILED AS OF DATE: 20180503 DATE AS OF CHANGE: 20180503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POPS RICHARD F CENTRAL INDEX KEY: 0001126490 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 18805651 MAIL ADDRESS: STREET 1: 10555 SCIENCE CENTER DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-01 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001126490 POPS RICHARD F 12780 EL CAMINO REAL SAN DIEGO CA 92130 1 0 0 0 Common Stock 2018-05-01 4 M 0 15000 7.05 A 44512 D Common Stock 2018-05-01 4 F 0 1253 84.39 D 43259 D Non-Qualified Stock Option 7.05 2018-05-01 4 M 0 15000 7.05 A 2011-06-25 2018-05-25 Common Stock 15000 0 D The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 25, 2011, which, if unexercised would have expired on May 25, 2018. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the Issuer's 2003 Equity Incentive Plan, as amended. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($7.05) was subtracted from the May 01, 2018 market close price ($84.39), and this net amount ($77.34) was then multiplied by the number of options (15,000), with the resulting amount then divided by the market close price to result in a net issuance of 13,747 shares to the optionee. The 1,253 shares underlying the remaining portion of the options are not available for re-issuance, and no shares were sold into the market as a part of the exercise in connection with a net issuance program. /s/ Darin Lippoldt, Attorney-in-Fact 2018-05-03